CAF-induced ECM remodeling can compress the vessels in the TME reducing drug delivery inside the tumor and CAF also secrete hypoxia-induced angiogenesis regulator (HIAR) and vascular endothelial growth factor (VEGF-A) promoting aberrant and exacerbated angiogenesis [60]. Here, NCBP2AS2 is linked to neoplasm.